|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.80 EUR | 0.00% |
|
-3.16% | -9.80% |
| 06-22 | MacroGenics to Receive $24.5 Million in Regulatory Milestone Payment | MT |
| 06-22 | European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading | MT |
| Market Cap | 87B 99.42B 80.41B 75.03B 141B 9,415B 142B 956B 371B 4,621B 373B 365B 16,066B | P/E 2026 * |
10.8x | P/E 2027 * | 10.1x |
|---|---|---|---|---|---|
| Enterprise Value | 97.81B 112B 90.39B 84.34B 158B 10,585B 160B 1,075B 417B 5,195B 420B 410B 18,061B | EV / Sales 2026 * |
2.08x | EV / Sales 2027 * | 1.9x |
| Free-Float |
89% | Yield 2026 * |
5.87% | Yield 2027 * | 6.22% |
Last Transcript: Sanofi
| 1 week | -3.16% | ||
| Current month | -1.60% | ||
| 1 month | -4.66% | ||
| 3 months | -6.12% | ||
| 6 months | -9.36% | ||
| Current year | -9.80% |
| 1 week | 36.8 |  | 37.8 |
| 1 month | 36.4 | | 38.8 |
| Current year | 36.2 | | 41.8 |
| 1 year | 36.2 | | 45 |
| 3 years | 36.2 | | 54.5 |
| 5 years | 36.2 | | 54.5 |
| 10 years | 31.4 | | 54.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 64 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 2023-09-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 56 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 64 | 2020-04-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -3.16% | - | - | 102B | |
| +0.32% | -2.73% | +44.49% | +143.28% | 980B | |
| +1.27% | -3.98% | +54.41% | +41.13% | 550B | |
| +6.25% | +1.00% | +24.13% | +68.06% | 382B | |
| +0.25% | -3.09% | +23.33% | +16.78% | 316B | |
| +0.42% | -1.28% | +27.89% | +14.71% | 272B | |
| +1.67% | -1.47% | +26.76% | +32.88% | 268B | |
| +2.39% | +4.42% | -36.96% | -45.12% | 199B | |
| +2.11% | -2.95% | +19.14% | +51.83% | 182B | |
| +0.90% | -0.57% | +15.09% | +60.89% | 154B | |
| Average | +0.76% | -2.70% | +22.03% | +42.72% | 366.93B | |
| Weighted average by Cap. | +0.47% | -3.50% | +31.28% | +65.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.07B 53.79B 43.5B 40.59B 76.16B 5,094B 76.82B 517B 201B 2,500B 202B 198B 8,691B | 49.98B 57.11B 46.19B 43.1B 80.87B 5,409B 81.57B 549B 213B 2,655B 214B 210B 9,229B |
| Net income | 8.15B 9.31B 7.53B 7.02B 13.18B 881B 13.29B 89.5B 34.74B 433B 34.94B 34.18B 1,504B | 8.95B 10.23B 8.28B 7.72B 14.49B 969B 14.62B 98.39B 38.2B 476B 38.42B 37.58B 1,654B |
| Net Debt | 10.8B 12.35B 9.98B 9.32B 17.48B 1,169B 17.63B 119B 46.08B 574B 46.35B 45.33B 1,995B | 8.08B 9.24B 7.47B 6.97B 13.08B 875B 13.19B 88.82B 34.48B 429B 34.68B 33.92B 1,493B |
| Date | Price | Change |
|---|---|---|
| 26-06-22 | 36.80 € | 0.00% |
| 26-06-19 | 36.80 € | -0.54% |
| 26-06-18 | 37.00 € | -2.12% |
| 26-06-17 | 37.80 € | +1.07% |
| 26-06-16 | 37.40 € | -1.06% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
- SNW2 Stock
Select your edition
All financial news and data tailored to specific country editions
